For example, tofacitinib a JAK inhibitor has been developed as a medicine for ulcerative colitis through the JAK-STAT pathway inhibition and has been recently approved by the FDA for ulcerative colitis [19]. The gene discussed is SOAT1; the disease is ulcerative colitis.